Suppr超能文献

随机、假对照试验 acupuncture 治疗白内障术后干眼疾病。

Randomized, sham-controlled trial of acupuncture for post-cataract surgery dry eye disease.

机构信息

Shanghai Research Institute of Acupuncture and Meridian, Shanghai University of Traditional Chinese Medicine, Shanghai, 200030, China.

Beijing University of Chinese Medicine, Beijing, 100105, China.

出版信息

Complement Ther Clin Pract. 2022 Nov;49:101680. doi: 10.1016/j.ctcp.2022.101680. Epub 2022 Nov 2.

Abstract

PURPOSE

To determine the efficacy of acupuncture in patients with post-cataract surgery dry eye disease (DED).

METHODS

Ninety participants with post-cataract surgery DED were randomly assigned (1:1) to receive true acupuncture (n = 44) or non-penetrating sham acupuncture (n = 46) twice weekly for 8 weeks. The primary outcome was the change from baseline to week 8 in the noninvasive tear film break-up time (TFBUT). Participants were followed until week 12. Secondary outcomes included Ocular Surface Disease Index (OSDI) score, tear meniscus height (TMH), corneal fluorescein staining (CFS) score, meiboscore and corrected distance visual acuity (CDVA).

RESULTS

The estimated mean change from baseline in the noninvasive TFBUT was 1.52 for true acupuncture versus 0.77 for sham acupuncture (adjusted difference -0.75 [95% CI -1.39 to -0.12]; P = 0.02) at week 8 and 1.49 for true acupuncture versus 0.81 for sham acupuncture (adjusted difference -0.68 [95% CI, -1.29 to -0.07]; P = 0.029) at week 12. The mean change in the OSDI score was -20.13 for true acupuncture versus -13.44 for sham acupuncture (adjusted difference 6.69 [95% CI, 0.64 to 12.74]; P = 0.031) at week 8, but revealed no statistically between-group differences at week 12. Mean changes in TMH, CFS score, meiboscore and CDVA did not differ significantly between the two groups.

CONCLUSIONS

Among patients with post-cataract surgery DED, acupuncture compared with sham acupuncture resulted in statistically significant benefit on tear film stability.

TRIAL REGISTRATION

Chinese Clinical Trial Registry (ChiCTR1800020132).

摘要

目的

评估针刺治疗白内障术后干眼(DED)的疗效。

方法

将 90 例白内障术后 DED 患者按 1:1 随机分为真针刺组(n=44)和非穿透假针刺组(n=46),每周治疗 2 次,共 8 周。主要结局指标为从基线到第 8 周非侵入性泪膜破裂时间(TFBUT)的变化。所有患者均随访至第 12 周。次要结局指标包括眼表疾病指数(OSDI)评分、泪膜高度(TMH)、角膜荧光素染色(CFS)评分、睑板腺评分和矫正视力(CDVA)。

结果

真针刺组 TFBUT 从基线的平均变化为 1.52,假针刺组为 0.77(调整后差异-0.75 [95% CI -1.39 至-0.12];P=0.02),第 8 周时真针刺组为 1.49,假针刺组为 0.81(调整后差异-0.68 [95% CI -1.29 至-0.07];P=0.029)。第 8 周时真针刺组 OSDI 评分的平均变化为-20.13,假针刺组为-13.44(调整后差异 6.69 [95% CI 0.64 至 12.74];P=0.031),但第 12 周时两组间无统计学差异。两组间 TMH、CFS 评分、睑板腺评分和 CDVA 的平均变化无显著差异。

结论

与假针刺相比,白内障术后 DED 患者针刺治疗可显著改善泪膜稳定性。

临床试验注册号

ChiCTR1800020132。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验